Table 2.
Group | N | Red Blood Cell Antibodies | p (Pre–Post) | Change in Red Blood Cell Antibodies | |
---|---|---|---|---|---|
Before Hemin Administration | After Hemin Administration | ||||
Negative allo-autoantibody thalassemia | 28 | 0.00±0. 00 (0–0) | 1.00±0.00 (0–2) | 0.000** | 1.00±0.00 (0–2) |
Positive allo-autoantibody thalassemia | 29 | 1.00±1.50 (0–4) | 1.00±0.00 (0–3) | 0.481 | 0.00±1.50 (−4–2) |
p (between groups) | 0.000* | 0.964 | 0.002* |
Notes: Data presented as mean ± SD and median (minimum–maximum). *Significant at p=0.05 (Mann–Whitney test). **Significant at p=0.05 (Wilcoxon signed-rank test).